semaglutide increase heart rate Evaluating the Cardiovascular Benefits of Innovator 2.4 mg (Recombinant DNA (r-DNA Semaglutide and heart rate: Understanding

Clinical trials show average weight loss of 14.9% over 68 weeks

Reducing intake of gas-producing foods can significantly alleviate symptoms

Study on the effect of active components of Schisandra chinensis on liver injury and its mechanisms in mice based on network pharmacology

These weight-loss measurements are lower than those recorded for other GLP-1 drugs, such as semaglutide, which are reported to result in mean weight reductions of 1520% and beyond

18 Most of these studies do not report HF diagnostic criteria or mention HF therapy, and only one trial reported on left ventricular ejection fraction (LVEF) at baseline